$-0.65
(Market cap
$0 Mln
Revenue (TTM)
$52 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-26 Mln
-
ROE
-1.6 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-24.2
-
Debt to Equity
1.4
-
Book Value
$--
-
EPS
$-4.8
-
Face value
--
-
Shares outstanding
8,878,582
5 Years Aggregate
CFO
$-128.71 Mln
EBITDA
$-75.55 Mln
Net Profit
$-177.09 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Minerva Surgical Inc (UTRS)
| -- | -- | -- | -- | -97.1 | -- | -- |
|
BSE Sensex*
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
Minerva Surgical Inc (UTRS)
| -73.8 | -95.7 |
|
S&P Small-Cap 600
| 13.9 | -17.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Minerva Surgical Inc (UTRS)
|
0.0 | 0.0 | 51.7 | -35.6 | -56.1 | -130.9 | -- | 0.0 |
| 62.1 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.9 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 58.9 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.3 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.9 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 321.9 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 168.8 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 28.7 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout Minerva Surgical Inc (UTRS)
Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion... System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities. It also offers Resectr, a tissue resection device to diagnose and treat polyps; and HERizon electronic disposable hysteroscope, image processor, Hysto-Kit, and endoscopic accessories that helps gynecologists to evaluate abnormal uterine bleeding and provide care. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Read more
-
President, CEO & Director
Mr. Todd Usen
-
President, CEO & Director
Mr. Todd Usen
-
Headquarters
Santa Clara, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Minerva Surgical Inc (UTRS)
What is the current share price of Minerva Surgical Inc (UTRS) Today?
The share price of Minerva Surgical Inc (UTRS) is $0.00 (NASDAQ) as of 02-Sep-2026 16:00 EDT. Minerva Surgical Inc (UTRS) has given a return of -97.11% in the last 3 years.
What is the current PB & PE ratio of Minerva Surgical Inc (UTRS)?
Since, TTM earnings of Minerva Surgical Inc (UTRS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-0.19 |
0.38 |
2021 |
-0.35 |
0.17 |
2020 |
-- |
-- |
2019 |
-- |
-- |
2022 |
-0.19 |
0.38 |
What is the 52 Week High and Low of Minerva Surgical Inc (UTRS)?
The 52-week high and low of Minerva Surgical Inc (UTRS) are Rs 0.00 and Rs 0.00 as of 04-Sep-2026.
What is the market cap of Minerva Surgical Inc (UTRS)?
Minerva Surgical Inc (UTRS) has a market capitalisation of $ 0 Mln as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Minerva Surgical Inc (UTRS)?
Before investing in Minerva Surgical Inc (UTRS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.